Vext Science, Inc.
VEXTF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $64,381 | $31,096 | $30,936 | $20,377 |
| - Cash | $3,702 | $4,551 | $4,826 | $4,625 |
| + Debt | $35,064 | $35,624 | $37,358 | $39,517 |
| Enterprise Value | $95,743 | $62,169 | $63,469 | $55,269 |
| Revenue | $12,670 | $13,407 | $11,561 | $10,194 |
| % Growth | -5.5% | 16% | 13.4% | – |
| Gross Profit | $3,969 | $4,872 | $2,278 | $2,136 |
| % Margin | 31.3% | 36.3% | 19.7% | 20.9% |
| EBITDA | $1,869 | $5,305 | $1,006 | -$2,008 |
| % Margin | 14.8% | 39.6% | 8.7% | -19.7% |
| Net Income | -$2,628 | -$1,478 | -$3,334 | -$9,215 |
| % Margin | -20.7% | -11% | -28.8% | -90.4% |
| EPS Diluted | -0.011 | -0.006 | -0.014 | -0.05 |
| % Growth | -72.1% | 54.8% | 72.8% | – |
| Operating Cash Flow | $1,259 | $4,175 | $3,082 | $4,015 |
| Capital Expenditures | -$1,123 | -$780 | -$814 | -$771 |
| Free Cash Flow | $136 | $3,395 | $2,268 | $3,244 |